CIEN Ciena

Previous close
$494.01
Est. 12 months change
-24.70%
Projected Price
$370.75

Profitability Metrics

Return on Equity (ROE)
8.22%
Return on Assets (ROA)
4.29%
Return on Invested Capital (ROIC)
10.71%
Weighted Average Cost of Capital (WACC)
10.30%
ROIC - WACC
0.41%
Updated : 2026-04-08 18:47 ET

Valuation Metrics

P/E Ratio
314.19
Forward P/E
77.75
PEG Ratio
1.03
Debt Current Ratio
2.81

Growth & Cash Flow

Gross Margin
42.13%
Operating Margin
8.19%
FCF Margin
14.48%
TTM Revenue Growth
33.09%
Projected 12M EPS Growth
304.13%

Price Change

Price % from 50 SMA
36.55%
Price % from 200 SMA
128.72%
6 Months
193.31%
1 Year
588.54%
2 Years
821.32%
Click here to see the list of ETFs containing CIEN as a top holding :Ciena ETFs

Analysis

Company Overview

Ciena provides intelligent networking technology and services used by carriers, cloud providers, and governments to build high-capacity optical and packet networks. Sector: Technology.

Overview

Ciena (CIEN) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 10.71%, WACC is 10.30%, and the economic spread is 0.41%. On balance, the economic spread is positive but compressed — adequate for value preservation, less convincing for aggressive compounding. Supporting metrics show ROE at 8.22% and ROA at 4.29%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

Valuation

On an earnings multiple basis, trailing P/E of 314.19, forward P/E of 77.75, PEG of 1.03. Forward P/E sits materially below trailing P/E, which supports the view that earnings expectations are improving and the company looks cheaper on forward numbers. At this PEG level, growth-adjusted valuation looks attractive — the market appears to be paying a reasonable price for the earnings growth embedded in estimates. A current ratio of 2.81 across the company reflects strong short-term liquidity. Combining multiples and liquidity, the company appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 42.13%, operating margin at 8.19%, and free cash flow margin at 14.48%. Gross margins are healthy, suggesting solid pricing power across the company. At this operating margin level, cost efficiency is present but limited — overhead is a visible drag on earnings conversion. At this FCF margin level, cash conversion is functional without being a standout feature of the company's quality profile. Read as a whole, the margin picture suggests a business with strengths in parts but no clear margin dominance end-to-end.

Growth & Forward Outlook

Connecting operational trends with market expectations, TTM revenue growth of 33.09% indicating strong organic momentum at the company level, while the estimated 12-month price change of -24.95%, where consensus targets point to downside risk over the next 12 months. At 304.1%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Overall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.

The analysis above draws from quantitative data only and does not constitute personalized financial advice. Investors should conduct independent research and consider professional guidance before acting on any information presented here.